Notably, RNA-Seq data from 43 head and neck cancers with matched normals from the TCGA database [16] consistently showed that tumour samples had a 2-fold elevated level of FJX1 when compared to the matched normals (p < 0.01) (Supplementary Figure S1b). The gene discussed is FJX1; the disease is head and neck cancer.